These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 5428170)

  • 1. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Dopa therapy in Parkinson's disease.
    Greer M
    J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779
    [No Abstract]   [Full Text] [Related]  

  • 4. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
    Gomirato G; Perfetti C
    Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of Parkinson's disease].
    Castaigne P; Rondot P; Ribadeau-Dumas JL
    Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of Parkinson's diseases].
    Lhermitte F; Degos CF
    Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Amantadine therapy in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's disease; modern treatment.
    Tolosa E
    Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 16. [The trial of intravenous L-DOPA in patients with Parkinson's disease].
    Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E
    Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G
    Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
    Shibazaki H
    Shinkei Kenkyu No Shimpo; 1971; 15(4):992-1002. PubMed ID: 4400830
    [No Abstract]   [Full Text] [Related]  

  • 19. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.